Share This

PR Newswire Asia's news > Health Care/Hospital

 |   Title only   |   Print    Next page > 
     
VYNDAMAX® (tafamidis) PBS-listed for adult patients with wild-type or hereditary transthyretin amyloid cardiomyopathy (ATTR-CM) with New York Heart Association (NYHA) Class I-II heart failure
VYNDAMAX has been listed on the Pharmaceutical Benefits Scheme (PBS) for adult patients with wild-type or hereditary transthyretin amyloid cardiomyopathy (ATTR-CM) with New York Heart Association (NYHA) ...
2024-05-04T    Health Care/Hospital   Medical/Pharmaceuticals 
United Imaging to Unveil Industry-Leading MRI Advancements at ISMRM 2024
Ultra-high-field technology, ultra-high-gradient technology, and advances in artificial intelligence take center stage. ...
2024-05-04T    Computer/Electronics   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
HanAll Biopharma Announces Initiation of Phase III Randomized, Double-Masked Vehicle Controlled VELOS-4 Trial Evaluating Tanfanercept for Treatment of Dry Eye Disease
HanAll has initiated a Phase III VELOS-4 study to evaluate the efficacy and safety of tanfanercept in dry eye based on the findings from the previous Phase III VELOS-3 study. Tanfanercept demonstrated ...
2024-05-03T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Hang Seng Insurance Introduces FortuneLife Deferred Annuity Life Insurance Plan with Enhanced Benefit to Support Stable Retirement
HONG KONG , May 3, 2024 /PRNewswire/ -- Hang Seng Insurance announced the launch of the enhanced version of the FortuneLife Deferred Annuity Life Insurance Plan ('FortuneLife'), a Qualifying ...
2024-05-03T    Banking/Financial Service   Health Care/Hospital   Insurance 
Boryung Launches 2024 Humans In Space Challenge: Sending Experiments into Orbit
Boryung to support the launch of space experiments into orbit for selected startups and researchers Held for the third consecutive year, HIS presents an expanded ecosystem of engagements with NASA, ...
2024-05-02T    Computer/Electronics   Health Care/Hospital 
Bio Basic Asia Pacific Offers Free Re-Sequencing and Gel Analysis for Sanger Sequencing Services
SINGAPORE , May 2, 2024 /PRNewswire/ -- Bio Basic Asia Pacific , the regional branch of BBI Life Sciences Corporation established in Singapore in 2016, announces an initiative to enhance the ...
2024-05-02T    Biotechnology   Computer/Electronics   Health Care/Hospital 
Clarivate Enhances Cortellis CMC Intelligence with Post-Approval Module to Accelerate Regulatory Success
Enhancements enable pharma, biotech and generics companies to streamline regulatory tracking and optimize life cycle management for small molecules and biologics  ...
2024-05-02T    Biotechnology   Computer Software   Computer/Electronics   Health Care/Hospital 
Vivo Surgical Announces Leading Gastrointestinal Endoscopists on Clinical Advisory Board for Novel Endoscopic Robot
Inaugural international clinical advisory board to provide strategic guidance towards development of the company's ERES™ endoscopic robot ...
2024-05-02T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
AXA partners with Prosper Health to expand "Healthcare and Wellness Ecosystem" in China
First global insurer in Hong Kong to collaborate with Prosper Health, providing seamless cross-border healthcare services ...
2024-05-02T    Banking/Financial Service   Health Care/Hospital   Insurance 
Everest Medicines Announces Hong Kong Department of Health Approval of Nefecon® for the Treatment for Primary IgA Nephropathy in Adult Patients
SHANGHAI , May 2, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company") announced that the Hong Kong Department of Health had approved Nefecon ® ...
2024-05-02T    Health Care/Hospital   Medical/Pharmaceuticals 
  Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.